Rajib Sarkar

North Eastern Hill University, 
Shillong, ML, IN 
North Eastern Hill University, 
Shillong, ML, IN 

Overview

Rajib Sarkar practices practicing medicine in Shillong, India.

Their clinical expertise encompasses Hemorrhoids, Heyde Syndrome, Crohn's Disease, Bone Graft, and Endoscopy.

They are actively involved in clinical research, co-authoring 36 peer reviewed articles and participating in 2 clinical trials.

Locations

North Eastern Hill University, Shillong, ML 793022, India
Other Locations
244, Acharya Jagadish Chandra Bose Road, Kolkata, WB 700020, India

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
Enrollment Status: Completed
Publish Date: May 13, 2026
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Enrollment Status: Completed
Publish Date: May 31, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
View 1 Less Clinical Trial

36 Total Publications

Harnessing alcohol side-chain reactivity in peptides and proteins: serine- and threonine-specific cleavage and conjugation.
Harnessing alcohol side-chain reactivity in peptides and proteins: serine- and threonine-specific cleavage and conjugation.
Journal: Organic & biomolecular chemistry
Published: August 28, 2026

Frequently Asked Questions about Rajib Sarkar

Is Rajib Sarkar a top-rated expert for Hemorrhoids?

MediFind is an objective health platform that identifies experts based on real-world data. Rajib Sarkar is classified as an Experienced expert for Hemorrhoids, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Rajib Sarkar participate in research or clinical trials?

Yes. Rajib Sarkar has published 36 articles and abstracts on conditions like Hemorrhoids. You can view a list of Rajib Sarkar's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Sarkar's expertise for a condition
ConditionClose
        View All 13 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile